Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2015-06-16 Legal Proceedings Report
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage continued success in re-examination proceedings
Legal Proceedings Report Classification · 95% confidence The document is a press release from Biotage AB dated June 16, 2015, detailing the successful conclusion of patent re-examination proceedings against Scientific Plastic Products, Inc. (SPP) concerning several US patents. It discusses legal actions, USPTO decisions, and future expectations regarding patent claims. This type of announcement, which reports on significant legal or regulatory matters involving the company, fits best under the 'Legal Proceedings Report' category. Although it is a press release, the core subject matter is the resolution of a major legal/patent dispute, making LTR more specific than the general 'RNS' fallback. The document length is relatively short (3338 chars), but it is reporting the *outcome* of the proceedings, not merely announcing that a report is available.
2015-06-16 English
Biotage – fortsatt framgång i omprövningsförfarande
Legal Proceedings Report Classification · 99% confidence The document is a press release dated June 16, 2015, detailing the outcome of a patent infringement case and subsequent patent review proceedings in the US Patent and Trademark Office (USPTO). It discusses the invalidation of several US patents belonging to a counterparty (SPP) following a legal challenge initiated by Biotage. This content relates to significant legal matters and regulatory actions involving the company. Since the document is a press release announcing the resolution of a major lawsuit/patent dispute, it fits best under the 'Legal Proceedings Report' category (LTR). It is not a standard financial report (10-K, IR, ER) or a management/board change announcement. It is a specific update on litigation.
2015-06-16 Swedish
Biotage AB launches share buy-back
Transaction in Own Shares Classification · 98% confidence The document is a press release from Biotage AB announcing that the board of directors has resolved to start a share buy-back program. The text explicitly mentions the authorization received from the Annual General Meeting for the acquisition and sale of the company's own shares. This action—the repurchase of the company's own stock—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing type code is POS.
2015-04-29 English
Beslut vid årsstämman i Biotage AB den 28 april 2015
AGM Information Classification · 99% confidence The document is titled 'Beslut vid årsstämman i Biotage AB den 28 april 2015' (Decisions at the Annual General Meeting in Biotage AB on April 28, 2015). It details specific resolutions passed regarding dividend distribution, election of the board and auditors, remuneration, and authorizations for share issues and repurchases, all typical outcomes of an Annual General Meeting (AGM). Although it is presented as a press release dated April 29, 2015, the core content is the official record of the AGM decisions. This aligns best with the 'AGM Information' category (AGM-R), which covers presentations and materials shared during the AGM. It is not a DVA (Declaration of Voting Results) because it focuses on the substantive decisions made, not just the final tally of votes, and it is more specific than a general Regulatory Filing (RNS).
2015-04-29 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January to March 2015. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it fits the definition of an Interim/Quarterly Report (IR). Q1 2015
2015-04-28 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report' and covers the period 'January - March 2015'. It contains detailed financial statements, including a consolidated statement of comprehensive income, balance sheet items, and management commentary on financial performance. It is a comprehensive quarterly report rather than a brief release or an announcement of a report, fitting the definition of an Interim/Quarterly Report (IR). Q1 2015
2015-04-28 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.